Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Gains from Investment Securities (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Gains from Investment Securities for 13 consecutive years, with -$1.7 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 166.88% to -$1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.5 million through Dec 2025, up 23.23% year-over-year, with the annual reading at $169806.0 for FY2025, 91.05% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$1.7 million at Theravance Biopharma, down from $2.0 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $2.5 million in Q4 2024, with the low at -$3.3 million in Q4 2023.
  • Average Gains from Investment Securities over 5 years is $306132.5, with a median of $179403.0 recorded in 2022.
  • The sharpest move saw Gains from Investment Securities plummeted 790.55% in 2022, then skyrocketed 32755.37% in 2024.
  • Over 5 years, Gains from Investment Securities stood at -$275000.0 in 2021, then crashed by 790.55% to -$2.4 million in 2022, then plummeted by 36.14% to -$3.3 million in 2023, then soared by 175.88% to $2.5 million in 2024, then tumbled by 166.88% to -$1.7 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$1.7 million, $2.0 million, and $169806.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.